Your browser doesn't support javascript.
loading
Novel cyclopeptides for the design of MMP directed delivery devices: a novel smart delivery paradigm.
Moustoifa, El-Farouck; Alouini, Mohamed-Anis; Salaün, Arnaud; Berthelot, Thomas; Bartegi, Aghleb; Albenque-Rubio, Sandra; Déléris, Gérard.
Afiliação
  • Moustoifa el-F; Université Victor Segalen Bordeaux 2, CNRS UMR 5084 Bio-Organic Chemistry Group, 146 rue Léo Saignat, F-33076, Bordeaux Cedex, France.
Pharm Res ; 27(8): 1713-21, 2010 Aug.
Article em En | MEDLINE | ID: mdl-20454838
PURPOSE: Matrix metalloproteinases (MMP) are a family of proteolytic enzymes, the expression of which in a key step of tumor progression has been better defined recently. The studies highlighted the ongoing need for very specific inhibitors, substrates or release devices designed to be selective for one or at least very few MMPs. METHODS: This report deals with the design, synthesis and in vitro evaluation of linear and especially novel cyclic peptidic moieties, embodying MMP cleavable sequences designed to answer these questions. FRET (fluorescence resonance energy transfer) labelling via chromophore-modified amino-acids was used to give access to enzyme kinetics. RESULTS: Evaluation of these peptides showed that cyclisation gives rise to high specificity for certain MMP, suggesting that this approach could provide very specific MMP substrate. Moreover, cyclic structures present a very good plasma stability. CONCLUSIONS: These original derivatives could allow the design of MMP-controlled delivery devices, the specificity of which will be retained in complex biological media and in vivo.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Peptídeos / Desenho de Fármacos / Sistemas de Liberação de Medicamentos / Inibidores de Metaloproteinases de Matriz Limite: Humans Idioma: En Revista: Pharm Res Ano de publicação: 2010 Tipo de documento: Article País de afiliação: França

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Peptídeos / Desenho de Fármacos / Sistemas de Liberação de Medicamentos / Inibidores de Metaloproteinases de Matriz Limite: Humans Idioma: En Revista: Pharm Res Ano de publicação: 2010 Tipo de documento: Article País de afiliação: França